133 related articles for article (PubMed ID: 10542333)
1. Alternative splicing of the Drosophila PTEN gene.
Smith A; Smith A; Alrubaie S; Coehlo C; Leevers SJ; Ashworth A
Biochim Biophys Acta; 1999 Oct; 1447(2-3):313-7. PubMed ID: 10542333
[TBL] [Abstract][Full Text] [Related]
2. Drosophila PTEN regulates cell growth and proliferation through PI3K-dependent and -independent pathways.
Gao X; Neufeld TP; Pan D
Dev Biol; 2000 May; 221(2):404-18. PubMed ID: 10790335
[TBL] [Abstract][Full Text] [Related]
3. Alternative splicing of the human PTEN/MMAC1/TEP1 gene.
Sharrard RM; Maitland NJ
Biochim Biophys Acta; 2000 Dec; 1494(3):282-5. PubMed ID: 11121587
[TBL] [Abstract][Full Text] [Related]
4. The biology and clinical relevance of the PTEN tumor suppressor pathway.
Sansal I; Sellers WR
J Clin Oncol; 2004 Jul; 22(14):2954-63. PubMed ID: 15254063
[TBL] [Abstract][Full Text] [Related]
5. TPIP: a novel phosphoinositide 3-phosphatase.
Walker SM; Downes CP; Leslie NR
Biochem J; 2001 Dec; 360(Pt 2):277-83. PubMed ID: 11716755
[TBL] [Abstract][Full Text] [Related]
6. Regulation of dauer larva development in Caenorhabditis elegans by daf-18, a homologue of the tumour suppressor PTEN.
Rouault JP; Kuwabara PE; Sinilnikova OM; Duret L; Thierry-Mieg D; Billaud M
Curr Biol; 1999 Mar; 9(6):329-32. PubMed ID: 10209098
[TBL] [Abstract][Full Text] [Related]
7. Drosophila tumor suppressor PTEN controls cell size and number by antagonizing the Chico/PI3-kinase signaling pathway.
Goberdhan DC; Paricio N; Goodman EC; Mlodzik M; Wilson C
Genes Dev; 1999 Dec; 13(24):3244-58. PubMed ID: 10617573
[TBL] [Abstract][Full Text] [Related]
8. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death.
Weng LP; Smith WM; Dahia PL; Ziebold U; Gil E; Lees JA; Eng C
Cancer Res; 1999 Nov; 59(22):5808-14. PubMed ID: 10582703
[TBL] [Abstract][Full Text] [Related]
9. Analysis of PTEN gene mutations in Korean patients with Cowden syndrome and polyposis syndrome.
Kim DK; Myung SJ; Yang SK; Hong SS; Kim KJ; Byeon JS; Lee GH; Kim JH; Min YI; Lee SM; Jeong JY; Song K; Jung SA
Dis Colon Rectum; 2005 Sep; 48(9):1714-22. PubMed ID: 16007494
[TBL] [Abstract][Full Text] [Related]
10. Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation.
Marsh DJ; Coulon V; Lunetta KL; Rocca-Serra P; Dahia PL; Zheng Z; Liaw D; Caron S; Duboué B; Lin AY; Richardson AL; Bonnetblanc JM; Bressieux JM; Cabarrot-Moreau A; Chompret A; Demange L; Eeles RA; Yahanda AM; Fearon ER; Fricker JP; Gorlin RJ; Hodgson SV; Huson S; Lacombe D; Eng C
Hum Mol Genet; 1998 Mar; 7(3):507-15. PubMed ID: 9467011
[TBL] [Abstract][Full Text] [Related]
11. PTEN and myotubularin: novel phosphoinositide phosphatases.
Maehama T; Taylor GS; Dixon JE
Annu Rev Biochem; 2001; 70():247-79. PubMed ID: 11395408
[TBL] [Abstract][Full Text] [Related]
12. Biallelic inactivating mutations and an occult germline mutation of PTEN in primary cervical carcinomas.
Kurose K; Zhou XP; Araki T; Eng C
Genes Chromosomes Cancer; 2000 Oct; 29(2):166-72. PubMed ID: 10959096
[TBL] [Abstract][Full Text] [Related]
13. Targeting mutants of PTEN reveal distinct subsets of tumour suppressor functions.
Leslie NR; Bennett D; Gray A; Pass I; Hoang-Xuan K; Downes CP
Biochem J; 2001 Jul; 357(Pt 2):427-35. PubMed ID: 11439092
[TBL] [Abstract][Full Text] [Related]
14. Mutation and expression analysis of the putative prostate tumour-suppressor gene PTEN.
Gray IC; Stewart LM; Phillips SM; Hamilton JA; Gray NE; Watson GJ; Spurr NK; Snary D
Br J Cancer; 1998 Nov; 78(10):1296-300. PubMed ID: 9823969
[TBL] [Abstract][Full Text] [Related]
15. The role of PTEN, a phosphatase gene, in inherited and sporadic nonmedullary thyroid tumors.
Eng C
Recent Prog Horm Res; 1999; 54():441-52; discussion 453. PubMed ID: 10548886
[TBL] [Abstract][Full Text] [Related]
16. PTEN: a tumour suppressor that functions as a phospholipid phosphatase.
Maehama T; Dixon JE
Trends Cell Biol; 1999 Apr; 9(4):125-8. PubMed ID: 10203785
[TBL] [Abstract][Full Text] [Related]
17. PTEN: life as a tumor suppressor.
Simpson L; Parsons R
Exp Cell Res; 2001 Mar; 264(1):29-41. PubMed ID: 11237521
[TBL] [Abstract][Full Text] [Related]
18. The tumour-suppressor function of PTEN requires an N-terminal lipid-binding motif.
Walker SM; Leslie NR; Perera NM; Batty IH; Downes CP
Biochem J; 2004 Apr; 379(Pt 2):301-7. PubMed ID: 14711368
[TBL] [Abstract][Full Text] [Related]
19. Mutations of PTEN in patients with Bannayan-Riley-Ruvalcaba phenotype.
Longy M; Coulon V; Duboué B; David A; Larrègue M; Eng C; Amati P; Kraimps JL; Bottani A; Lacombe D; Bonneau D
J Med Genet; 1998 Nov; 35(11):886-9. PubMed ID: 9832032
[TBL] [Abstract][Full Text] [Related]
20. Association of splicing defects in PTEN leading to exon skipping or partial intron retention in Cowden syndrome.
Celebi JT; Wanner M; Ping XL; Zhang H; Peacocke M
Hum Genet; 2000 Sep; 107(3):234-8. PubMed ID: 11071384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
